BCL2L2 Antikörper (full length)
Kurzübersicht für BCL2L2 Antikörper (full length) (ABIN6654581)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- Bcl2L2 Antibody / Bcl-W
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Full-length recombinant human protein was used as the immunogen for this Bcl2L2 antibody.
-
Isotyp
- IgG1
-
-
anti-BCL2-Like 2 (BCL2L2) (AA 6-118) antibody
BCL2L2 Reaktivität: Human IHC, ELISA, ICC, FACS Wirt: Maus Monoclonal 4G12E6 unconjugated
anti-BCL2-Like 2 (BCL2L2) (AA 2-193) antibodyBCL2L2 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 2 (BCL2L2) antibodyKD Validated BCL2L2 Reaktivität: Human WB, ICC, FACS Wirt: Kaninchen Monoclonal 24GB365 unconjugated Recombinant Antibody
anti-BCL2-Like 2 (BCL2L2) (AA 24-59) antibodyBCL2L2 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB0972 unconjugated
anti-BCL2-Like 2 (BCL2L2) antibodyBCL2L2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal CPTC-BCL2L2-2 unconjugated
anti-BCL2-Like 2 (BCL2L2) (AA 1-193) antibodyBCL2L2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E4 unconjugated
anti-BCL2-Like 2 (BCL2L2) (N-Term) antibodyBCL2L2 Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 2 (BCL2L2) (AA 2-193) antibodyBCL2L2 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 2 (BCL2L2) (AA 1-193) antibodyBCL2L2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 2 (BCL2L2) (BH3 Domain) antibodyBCL2L2 Reaktivität: Human, Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the Bcl2L2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- Bcl2L2
-
Hintergrund
- Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
UniProt
- Q92843
Target
-
